Krystal Biotech, Inc. Common Stock (KRYS) Stock
Fundamentals
Latest news
About Krystal Biotech, Inc. Common Stock
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Krish S. Krishnan M.B.A., M.S. | Founder, Chairman, President & CEO | 1965 |
| Ms. Suma M. Krishnan | Founder, President of R&D and Director | 1965 |
| Ms. Kathryn A. Romano CPA | Executive VP & Chief Accounting Officer | 1982 |
| Mr. John C. Thomas | EVP, General Counsel & Corporate Secretary | 1974 |
| Mr. John Karakkal | Vice President of North American Sales & Marketing | — |
| Dr. Stephane Paquette Ph.D. | Senior Vice President of Corporate Development | — |
| Mr. Josh Suskin | Senior Director & Head of US Human Resources | — |
| Mr. Laurent Goux | Executive VP & Head of International | 1975 |
| Dr. David Chien M.D. | Senior Vice President of Clinical Development | — |
| Ms. Christine Wilson | Senior VP & Head of US Commercial | — |



